SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,003 | -54.6% | 26,385 | +3.7% | 0.00% | -42.9% |
| Q2 2023 | $1,196,518 | +13.4% | 25,447 | +1.2% | 0.01% | 0.0% |
| Q1 2023 | $1,054,958 | +12.3% | 25,142 | +2.0% | 0.01% | 0.0% |
| Q4 2022 | $939,808 | -2.9% | 24,641 | -0.4% | 0.01% | 0.0% |
| Q3 2022 | $968,000 | +22.8% | 24,731 | +1.4% | 0.01% | +40.0% |
| Q2 2022 | $788,000 | +4277.8% | 24,381 | +4440.2% | 0.01% | – |
| Q1 2022 | $18,000 | -21.7% | 537 | -2.7% | 0.00% | – |
| Q4 2021 | $23,000 | -8.0% | 552 | -3.5% | 0.00% | – |
| Q3 2021 | $25,000 | -30.6% | 572 | -10.9% | 0.00% | – |
| Q2 2021 | $36,000 | -26.5% | 642 | -1.5% | 0.00% | – |
| Q1 2021 | $49,000 | -19.7% | 652 | -8.0% | 0.00% | – |
| Q4 2020 | $61,000 | +38.6% | 709 | -1.0% | 0.00% | – |
| Q3 2020 | $44,000 | +46.7% | 716 | -1.0% | 0.00% | – |
| Q2 2020 | $30,000 | -9.1% | 723 | -37.8% | 0.00% | – |
| Q1 2020 | $33,000 | -61.2% | 1,162 | -1.8% | 0.00% | – |
| Q4 2019 | $85,000 | -50.9% | 1,183 | -4.1% | 0.00% | -100.0% |
| Q3 2019 | $173,000 | -23.5% | 1,233 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $226,000 | +33.7% | 1,233 | +16.3% | 0.00% | 0.0% |
| Q1 2019 | $169,000 | +61.0% | 1,060 | -3.5% | 0.00% | – |
| Q4 2018 | $105,000 | -32.3% | 1,098 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $155,000 | -9.9% | 1,098 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $172,000 | -96.0% | 1,098 | -95.9% | 0.00% | -93.3% |
| Q1 2018 | $4,337,000 | +3.3% | 26,925 | +5.7% | 0.02% | +7.1% |
| Q4 2017 | $4,197,000 | +190.7% | 25,483 | +10.0% | 0.01% | +180.0% |
| Q3 2017 | $1,444,000 | -15.5% | 23,174 | +8.1% | 0.01% | -16.7% |
| Q2 2017 | $1,708,000 | +31.6% | 21,441 | +17.4% | 0.01% | +20.0% |
| Q1 2017 | $1,298,000 | +66.8% | 18,262 | +19.9% | 0.01% | +66.7% |
| Q4 2016 | $778,000 | -99.9% | 15,231 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $703,230,000 | +53.1% | 15,271 | +0.2% | 0.00% | +50.0% |
| Q2 2016 | $459,422,000 | +77.4% | 15,248 | +88.7% | 0.00% | +100.0% |
| Q1 2016 | $259,000,000 | -45.0% | 8,079 | +0.1% | 0.00% | -50.0% |
| Q4 2015 | $471,000,000 | +137619.3% | 8,074 | -0.2% | 0.00% | +100.0% |
| Q3 2015 | $342,000 | -99.9% | 8,088 | +0.1% | 0.00% | -50.0% |
| Q2 2015 | $589,767,000 | +224.8% | 8,079 | +123.5% | 0.00% | +100.0% |
| Q1 2015 | $181,581,000 | +37.2% | 3,615 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $132,309,000 | – | 3,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |